[Extrapolation of data to inform system-level decisions of the Federal Joint Committee].
The evaluation procedures of the Federal Joint Committee (G-BA) often raise the question of whether and under what conditions findings can be transferred to other areas of application or interventions. Additional information is required in each case to test transferability. On the basis of selected examples from the decision-making practice of the G-BA, the complex weighing processes are outlined and the need for transparent illustration of the reasons for decisions is pointed out. The criteria, which in any case must be examined, cannot be described conclusively. Depending on the concrete question - method, pharmaceutical - further criteria may be relevant. A systematic approach still has to be developed so that the complex weighing processes could be simplified by transfer assumptions with sufficient certainty.